Corticosteroid — IV
Pregnancy: Use with caution; prednisolone preferred in pregnancy (less placental transfer)
Methylprednisolone
Brand names: Solu-Medrone
Adult dose
Dose: 1-2 g IV (spinal cord injury); 500 mg-1 g IV (severe asthma/exacerbation); 125 mg IV (anaphylaxis adjunct)
Route: Intravenous
Frequency: Once daily for defined course; anaphylaxis: single dose
Max: 2 g/day
Acute spinal cord injury: 30 mg/kg IV bolus over 15 min, then 5.4 mg/kg/hr for 23 hours (NASCIS II protocol — use remains controversial; specialist decision). Severe asthma: 125-500 mg IV once daily. Anaphylaxis: 200 mg IV after adrenaline
Paediatric dose
Dose: 1-2 mg/kg IV (severe asthma); 30 mg/kg (spinal cord injury, specialist only) mg/kg
Route: IV
Frequency: Once daily or single dose
Max: 1 g/day (asthma)
Severe asthma: 1-2 mg/kg IV once daily (max 60 mg). Spinal injury: seek specialist opinion. Anaphylaxis: 2 mg/kg IV
Dose adjustments
Renal
No dose adjustment required
Hepatic
Use with caution in severe hepatic impairment
Paediatric weight-based calculator
Severe asthma: 1-2 mg/kg IV once daily (max 60 mg). Spinal injury: seek specialist opinion. Anaphylaxis: 2 mg/kg IV
Clinical pearls
- 4x more potent than prednisolone and 5x more potent than hydrocortisone on an mg basis — dose conversions are critical
- NASCIS spinal cord injury protocol remains controversial — benefit limited to specific timing windows (within 8 hours); not universally recommended; NICE and AOSPINE do not routinely endorse
- Hyperglycaemia is a predictable effect with high-dose IV steroids — monitor glucose 4-hourly; insulin sliding scale may be needed
- In life-threatening asthma: IV methylprednisolone not superior to oral prednisolone in published evidence when oral route is possible — IV reserved for patients unable to swallow
- Sodium succinate formulation (Solu-Medrone): requires reconstitution; some formulations contain benzyl alcohol — avoid in neonates
Contraindications
- Systemic infections (without antimicrobial cover)
- Live vaccines
Side effects
- Hyperglycaemia (rapid onset with IV)
- Hypertension
- Fluid retention
- GI bleeding (with NSAIDs)
- Psychiatric effects (mania, psychosis)
- Immunosuppression
- Hypothalamic-pituitary-adrenal suppression (prolonged use)
Interactions
- NSAIDs (additive GI bleeding risk)
- Ciclosporin (mutual interaction — both levels affected)
- Antidiabetics (raise blood glucose)
- Warfarin (variable effect — monitor INR)
Monitoring
- Blood glucose
- Blood pressure
- Electrolytes (sodium, potassium)
- Signs of infection
Reference: BNFc; BNF 90; NASCIS II Protocol; BTS/SIGN Asthma Guidelines; NICE NG80; WAO Anaphylaxis Guidelines. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Pathways
- Paracetamol overdose · TOXBASE/NPIS; MHRA DSU 2012/2024; SNAP regimen (Lancet 2014); BNF
- TCA overdose · TOXBASE/NPIS; AACT/EAPCCT position statements; Resuscitation Council UK ALS
- Opioid overdose · TOXBASE/NPIS; Resuscitation Council UK; BNF
- Anticholinergic toxidrome · TOXBASE/NPIS; AACT/EAPCCT; BNF
- Benzodiazepine overdose · TOXBASE/NPIS; AACT/EAPCCT; BNF
- β-blocker overdose · TOXBASE/NPIS; AACT/EAPCCT; ESC; BNF